Teladoc | Diabetes and Weight Management Part 1-Pharmacological Agents for Diabetes & Obesity Infographic

Pharmacological Agents for Diabetes & Obesity Infographic

Pdf Summary

This infographic provides guidelines for the use of pharmacologic agents in the treatment of diabetes and obesity based on recommendations from the American Diabetes Association's Standards of Care in Diabetes 2023. Incretins and weight management are highlighted as key treatments for type 2 diabetes. They have been shown to delay the progression from prediabetes to type 2 diabetes and are highly beneficial in treating type 2 diabetes. Incretins also help improve glycemia and reduce the need for glucose-lowering medications. Additionally, they substantially reduce A1C and fasting glucose levels and have been shown to promote sustained diabetes remission for at least two years. In terms of weight management, there is strong and consistent evidence that obesity management can aid in achieving and maintaining meaningful weight loss and reducing obesity-associated health risks.<br /><br />The infographic also presents treatment options for overweight and obesity in type 2 diabetes based on body mass index (BMI) categories. These options include intensive behavioral counseling, obesity pharmacotherapy, and bariatric surgery. The choice of glucose-lowering medications should take into consideration the patient's weight, and medications that are associated with weight gain should be minimized. Obesity pharmacotherapy can be effective as an adjunct to nutrition, physical activity, and behavioral counseling for selected individuals with type 2 diabetes and a BMI of 27 kg/m2 or higher. However, the potential benefits and risks of pharmacotherapy must be considered. The infographic also provides a list of specific glucose-lowering medications categorized as very high, high, intermediate, or neutral, based on their potential for weight loss. Overall, this infographic serves as a visual guide to the guidelines for the use of pharmacologic agents in the management of diabetes and obesity.

Keywords

pharmacologic agents

diabetes treatment

obesity management

American Diabetes Association

incretins

weight management

type 2 diabetes

BMI categories

glucose-lowering medications

obesity pharmacotherapy